1
|
Castillo-Rangel C, Marin G, Hernández-Contreras KA, Vichi-Ramírez MM, Zarate-Calderon C, Torres-Pineda O, Diaz-Chiguer DL, De la Mora González D, Gómez Apo E, Teco-Cortes JA, Santos-Paez FDM, Coello-Torres MDLÁ, Baldoncini M, Reyes Soto G, Aranda-Abreu GE, García LI. Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review. Int J Mol Sci 2023; 24:ijms24065792. [PMID: 36982866 PMCID: PMC10051221 DOI: 10.3390/ijms24065792] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 03/13/2023] [Accepted: 03/14/2023] [Indexed: 03/22/2023] Open
Abstract
Parkinson’s disease is a neurodegenerative disease whose progression and clinical characteristics have a close bidirectional and multilevel relationship with the process of neuroinflammation. In this context, it is necessary to understand the mechanisms involved in this neuroinflammation–PD link. This systematic search was, hereby, conducted with a focus on the four levels where alterations associated with neuroinflammation in PD have been described (genetic, cellular, histopathological and clinical-behavioral) by consulting the PubMed, Google Scholar, Scielo and Redalyc search engines, including clinical studies, review articles, book chapters and case studies. Initially, 585,772 articles were included, and, after applying the inclusion and exclusion criteria, 84 articles were obtained that contained information about the multilevel association of neuroinflammation with alterations in gene, molecular, cellular, tissue and neuroanatomical expression as well as clinical-behavioral manifestations in PD.
Collapse
Affiliation(s)
- Carlos Castillo-Rangel
- Neurosurgery Department, “Hospital Regional 1° de Octubre”, Institute of Social Security and Services for State Workers (ISSSTE), México City 07300, Mexico
| | - Gerardo Marin
- Neural Dynamics and Modulation Lab, Cleveland Clinic, Cleveland, OH 44195, USA
- Correspondence: ; Tel.: +52-296-102-5707
| | | | | | | | | | - Dylan L. Diaz-Chiguer
- Neurosurgery Department, “Hospital Regional 1° de Octubre”, Institute of Social Security and Services for State Workers (ISSSTE), México City 07300, Mexico
| | | | - Erick Gómez Apo
- Pathology Department, “Hospital General de México”, Dr. Eduardo Liceaga, México City 06720, Mexico
| | | | | | | | - Matías Baldoncini
- Laboratory of Microsurgical Neuroanatomy, Second Chair of Gross Anatomy, University of Buenos Aires, Buenos Aires C1052AAA, Argentina
| | | | | | - Luis I. García
- Brain Research Institute, Universidad Veracruzana, Xalapa 91192, Mexico
| |
Collapse
|
2
|
Ramos-García NA, Orozco-Ibarra M, Estudillo E, Elizondo G, Gómez Apo E, Chávez Macías LG, Sosa-Ortiz AL, Torres-Ramos MA. Aryl Hydrocarbon Receptor in Post-Mortem Hippocampus and in Serum from Young, Elder, and Alzheimer's Patients. Int J Mol Sci 2020; 21:ijms21061983. [PMID: 32183254 PMCID: PMC7139760 DOI: 10.3390/ijms21061983] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Revised: 03/09/2020] [Accepted: 03/10/2020] [Indexed: 11/16/2022] Open
Abstract
One of the characteristics of the cerebral aging process is the presence of chronic inflammation through glial cells, which is particularly significant in neurodegeneration. On the other hand, it has been demonstrated that the aryl hydrocarbon receptor (AHR) participates in the inflammatory response. Currently, evidence in animal models shows that the hallmarks of aging are associated with changes in the AHR levels. However, there is no information concerning the behavior and participation of AHR in the human aging brain or in Alzheimer’s disease (AD). We evaluated the expression of AHR in human hippocampal post-mortem tissue and its association with reactive astrocytes by immunohistochemistry. Besides this, we analyzed through ELISA the AHR levels in blood serum from young and elder participants, and from AD patients. The levels of AHR and glial fibrillar acid protein were higher in elder than in young post-mortem brain samples. AHR was localized mainly in the cytosol of astrocytes and displayed a pattern that resembles extracellular vesicles; this latter feature was more conspicuous in AD subjects. We found higher serum levels of AHR in AD patients than in the other participants. These results suggest that AHR participates in the aging process, and probably in the development of neurodegenerative diseases like AD.
Collapse
Affiliation(s)
- Nicte Alaide Ramos-García
- Unidad Periférica de Neurociencias, Instituto Nacional de Neurología y Neurocirugía/Universidad Nacional Autónoma de México. Av. Insurgentes Sur No. 3877 Col. La Fama, Tlalpan, C.P. 14269, Ciudad de México, Mexico;
- Departamento de Biología Celular, CINVESTAV-IPN, Av. Instituto Politécnico Nacional No. 2508, Col. San Pedro Zacatenco, Gustavo A. Madero, C.P. 07360, Ciudad de México, Mexico;
| | - Marisol Orozco-Ibarra
- Laboratorio de Neurobiología Molecular y Celular, Instituto Nacional de Neurología y Neurocirugía. Av. Insurgentes Sur No. 3877 Col. La Fama, Tlalpan, C.P. 14269, Ciudad de México, Mexico;
| | - Enrique Estudillo
- Laboratorio de Reprogramación Celular, Instituto Nacional de Neurología y Neurocirugía/Universidad Nacional Autónoma de México. Av. Insurgentes Sur No. 3877 Col. La Fama, Tlalpan, C.P. 14269, Ciudad de México, Mexico;
| | - Guillermo Elizondo
- Departamento de Biología Celular, CINVESTAV-IPN, Av. Instituto Politécnico Nacional No. 2508, Col. San Pedro Zacatenco, Gustavo A. Madero, C.P. 07360, Ciudad de México, Mexico;
| | - Erick Gómez Apo
- Hospital General de México, “Dr. Eduardo Liceaga”. Dr. Balmis No. 148, Col. Doctores, Cuauhtémoc, C.P. 06720, Ciudad de México, Mexico; (E.G.A.); (L.G.C.M.)
| | - Laura Graciela Chávez Macías
- Hospital General de México, “Dr. Eduardo Liceaga”. Dr. Balmis No. 148, Col. Doctores, Cuauhtémoc, C.P. 06720, Ciudad de México, Mexico; (E.G.A.); (L.G.C.M.)
| | - Ana Luisa Sosa-Ortiz
- Laboratorio de Demencias, Instituto Nacional de Neurología y Neurocirugía, Av. Insurgentes Sur No. 3877 Col. La Fama, Tlalpan, C.P. 14269, Ciudad de México, Mexico;
| | - Mónica Adriana Torres-Ramos
- Unidad Periférica de Neurociencias, Instituto Nacional de Neurología y Neurocirugía/Universidad Nacional Autónoma de México. Av. Insurgentes Sur No. 3877 Col. La Fama, Tlalpan, C.P. 14269, Ciudad de México, Mexico;
- Correspondence: ; Tel.: +52-55-56063822 (ext. 3045)
| |
Collapse
|
3
|
Beltrán JQ, Soto-Abraham JE, Vidaurreta-Serrano J, Macias LGC, Apo EG, Ogando-Rivas E. Astrocytic Tumors in Mexico: An Overview of Characteristics and Prognosis in an Open Reference Center for Low-Income Population. J Neurosci Rural Pract 2019; 9:516-521. [PMID: 30271043 PMCID: PMC6126285 DOI: 10.4103/jnrp.jnrp_106_18] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Objective: The authors aimed to analyze the current epidemiology of high- and low-grade gliomas, follow-up strategies, and prognosis in a national reference center of a developing country. Materials and Methods: Medical records of patients diagnosed with intracranial gliomas from January 2012 to January 2016 were reviewed. Data were classified by age, symptoms, Karnofsky functional scale (KFS), tumor location, extent of resection (EOR), histopathology, hospital stay, Glasgow outcome scale (GOS), adjuvant treatments, overall survival (OS), and mortality. Results: Astrocytomas accounted for 28.2% of the intracranial tumors and 53.5% were male. Headache was the most common symptom, while sensory disturbance was the least frequent. The right cerebral hemisphere was involved in 56.5% of cases and frontal lobe in 31.3%. Gross total resection (GTR) was achieved in 18.1% cases, 35.3% subtotal resection, and 46.4% biopsy. Regarding the astrocytomas, 43.3% were low grade and 56.4% high grade. Low-grade tumors had the highest frequency in the fourth decade of life, while Grade III and IV in the fifth and seventh decades of life, respectively. In high-grade lesions, there was a slight male predominance (~1.4:1). The initial KFS was regularly 80 for low-grade gliomas and 60 for high-grade. By 1-month postdischarge, the score decreased by 10 points. About half of the patients (47.5%) received adjuvant therapy after surgery. From the Glasgow Outcome Scale (GOS), the majority had a form of disability and 30-month OS was above 88% for Grade I-II and 0% for Grade III and IV. Conclusions: Astrocytic tumors were the most frequently noted intra-axial tumors. Age, histological grade, and EOR are important prognostic factors. These results are similar to other reports; however, increased variability was noted when treatment-related factors were considered. Additional studies are necessary to identify the factors related to these treatment results. Highlights: There are no data describing the basic epidemiology and prognosis of high-grade and low-grade gliomas in Mexico. Intracranial astrocytomas account for 28.2% tumors in our institution. Age, histological grade, and EOR are important prognostic factors. Poor overall survival was achieved in our target population.
Collapse
Affiliation(s)
| | - Julian Eduardo Soto-Abraham
- Department of Neurosurgery, Hospital General de México, Mexico City, Mexico.,Department of Functional Neurosurgery, Hospital General de México, Mexico City, Mexico
| | | | | | - Erick Gómez Apo
- Department of Neuropathology, Hospital General de México, Mexico City, Mexico
| | - Elizabeth Ogando-Rivas
- Department of Neurosurgery, University of Florida, Gainesville, FL, USA.,Department of Neurosurgery, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL, USA
| |
Collapse
|
4
|
Abril PAE, Salazar MF, García NLL, Moya MNM, Guerra YUZ, Mendoza YGM, Apo EG, Macías LGC. Erratum: WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm. J Pathol Transl Med 2015; 49:538. [PMID: 26612551 PMCID: PMC4696522 DOI: 10.4132/jptm.2015.05.20.r] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
| | - Miguel Fdo Salazar
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Nubia L López García
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Mónica N Madrazo Moya
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Yadir U Zamora Guerra
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | | | - Erick Gómez Apo
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Laura G Chávez Macías
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| |
Collapse
|
5
|
Escalante Abril PA, Salazar MF, López García NL, Madrazo Moya MN, Zamora Guerra YU, Mata Mendoza YG, Gómez Apo E, Chávez Macías LG. WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm. J Pathol Transl Med 2015; 49:325-30. [PMID: 26081826 PMCID: PMC4508570 DOI: 10.4132/jptm.2015.05.20] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2015] [Revised: 05/10/2015] [Accepted: 05/20/2015] [Indexed: 11/27/2022] Open
Abstract
We report a 50-year-old woman with no relevant clinical history who presented with headache and loss of memory. Magnetic resonance imaging showed a left parieto-temporal mass with annular enhancement after contrast media administration, rendering a radiological diagnosis of high-grade astrocytic neoplasm. Tumour sampling was performed but the patient ultimately died as a result of disease. Microscopically, the lesion had areas of glioblastoma mixed with a benign mesenchymal constituent; the former showed hypercellularity, endothelial proliferation, high mitotic activity and necrosis, while the latter showed fascicles of long spindle cells surrounded by collagen and reticulin fibers. With approximately 40 previously reported cases, gliofibroma is a rare neoplasm defined as either glio-desmoplastic or glial/benign mesenchymal. As shown in our case, its prognosis is apparently determined by the degree of anaplasia of the glial component.
Collapse
Affiliation(s)
| | - Miguel Fdo Salazar
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Nubia L López García
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Mónica N Madrazo Moya
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Yadir U Zamora Guerra
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | | | - Erick Gómez Apo
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Laura G Chávez Macías
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| |
Collapse
|
6
|
Salazar MF, Estrada Hernández MDR, Gómez Apo E, Chávez Macías LG, Rodríguez Álvarez CA. Paediatric Primary Pachymeningeal Xanthogranuloma with Scattered Foci Displaying Reticulohistiocytoma-like Features. J Pathol Transl Med 2015; 49:403-8. [PMID: 26081827 PMCID: PMC4579281 DOI: 10.4132/jptm.2015.05.28] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2015] [Revised: 04/27/2015] [Accepted: 05/28/2015] [Indexed: 12/30/2022] Open
Abstract
We report a unique case of a 4-year-old girl with an intriguing fibrohistiocytic tumour. Magnetic resonance imaging scans showed a dural mass of variegated intensity compressing the left occipital pole and apparently extending toward the superior sagittal sinus. Grossly, the cut surface of the surgical specimen was yellow, pale, and soft with reddish kernel-like crusts. Histologically, the yellow areas resembled cholesterol granulomas with widespread coagulative necrosis, cholesterol clefts, powdery calcification, foreign body-type giant cells, and foamy macrophages, while the scattered red spots contained numerous multinucleated giant cells of foreign-body and Touton types, the former with amphophilic to slightly eosinophilic cytoplasm. Immunoperoxidase reactions confirmed the expression of histiocytic markers and vimentin. As far as we know, no tumour displaying these peculiar morphological features has yet been described.
Collapse
Affiliation(s)
- Miguel Fdo Salazar
- Anatomical Pathology Division, "Dr. Manuel Gea González" General Hospital, Mexico City, Mexico ; Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | | | - Erick Gómez Apo
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | - Laura G Chávez Macías
- Pathology Unit, Neuropathology Service, Mexico General Hospital, Mexico City, Mexico
| | | |
Collapse
|